Probiotic Supplementation Among Adults With Recurrent Gastrointestinal Symptoms

Exclusion Criteria

• •1. Current and documented diagnosis of Inflammatory Bowel Disease (Crohn's disease or ulcerative colitis), Celiac disease, active peptic ulcer, active diverticulitis, and other active cases of gastrointestinal diseases that, in the investigators' opinions, may affect participant safety.
• •2. Current and documented diagnosis of any other non-gastrointestinal disease that, in the investigators' opinions, may affect participant safety or confound the evaluation of the study outcomes. Excluded conditions include congestive heart failure, malignancy, uncontrolled diabetes mellitus, uncontrolled autoimmune disease (lupus, rheumatoid arthritis, eczema), eating disorders, and any other active health condition or disease that the investigators feel contradict the intended study population of participants in good health.
• •3. Daily consumption of another probiotic supplement or new consumption of fermented dairy products (yogurt, kefir, etc.)
• •4. Usage of systemic steroids during the past 2 months
• •5. Usage of antipsychotic medications during the past 2 months
• •6. Usage of prednisone, 6-mercaptopurine, adalimumab, etanercept, infliximab, leflunomide, golimumab, or mycophenolate mofetil during the past 2 months
• •7. Uncontrolled anxiety or current medication for anxiety disorder
• •8. Pregnant or breastfeeding females
• •9. History of alcohol, drug, or medication abuse
• •10. Known allergies to any substance in the study product
• •11. Previous major gastrointestinal tract surgery (colon resection, gastric bypass, etc.)
• •12. Participation in another clinical trial within 30 days of screening